Evidence map›Paper›PMID 30805668›Full record

ArticlePsychopharmacology2019

Multi-modal antidepressant-like action of 6- and 7-chloro-2-aminodihydroquinazolines in the mouse tail suspension test.

Kavita A Iyer, Katie Alix, Jose M Eltit, Ernesto Solis, Xiaolei Pan, Malaika D Argade, Shailesh Khatri, Louis J De Felice, Douglas H Sweet, Marvin K Schulte and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Psychopharmacology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.0field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Effect of Kruppel-like factor 4 on PTZ-induced acute seizure mice.Journal of cellular and molecular medicine · 2024
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Organic Cation Transporter Expression and Function in the CNS.Handbook of experimental pharmacology · 2021
    Article
  11. Organic Cation Transporters in Psychiatric Disorders.Handbook of experimental pharmacology · 2021
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Kavita A IyerDepartment of Medicinal Chemistry, School of Pharmacy, Virginia Commonwealth University, PO Box 980540, Richmond, VA, 23298-540, USA.
Katie AlixDepartment of Medicinal Chemistry, School of Pharmacy, Virginia Commonwealth University, PO Box 980540, Richmond, VA, 23298-540, USA.
Jose M EltitDepartment of Physiology and Biophysics, School of Medicine, Virginia Commonwealth University, Richmond, VA, 23298, USA.
Ernesto SolisDepartment of Physiology and Biophysics, School of Medicine, Virginia Commonwealth University, Richmond, VA, 23298, USA.
Xiaolei PanDepartment of Pharmaceutics, School of Pharmacy, Virginia Commonwealth University, Richmond, VA, 23298, USA.
Malaika D ArgadeDepartment of Medicinal Chemistry, School of Pharmacy, Virginia Commonwealth University, PO Box 980540, Richmond, VA, 23298-540, USA.
Shailesh KhatriDepartment of Pharmaceutical Sciences, Philadelphia College of Pharmacy, University of Sciences, Philadelphia, PA, 19104, USA.
Louis J De FeliceDepartment of Physiology and Biophysics, School of Medicine, Virginia Commonwealth University, Richmond, VA, 23298, USA.
Douglas H SweetDepartment of Pharmaceutics, School of Pharmacy, Virginia Commonwealth University, Richmond, VA, 23298, USA.
Marvin K SchulteDepartment of Biomedical and Pharmaceutical Sciences, College of Pharmacy, Kasiska Division of Health Sciences, Idaho State University, Pocatello, ID, 83209, USA.
Małgorzata DukatDepartment of Medicinal Chemistry, School of Pharmacy, Virginia Commonwealth University, PO Box 980540, Richmond, VA, 23298-540, USA. mdukat@vcu.edu.ORCID http://orcid.org/0000-0003-4349-1615
Virginia Commonwealth University · USIdaho State University · USUniversity of the Sciences · US

Funding

Synthetic cathinones: a new class of illicit drugs affecting DAT & SERTR01DA033930 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI ELTIT, JOSE MIGUEL, GLENNON, RICHARD A · 2012 to 2016
$2.7M
National Institute on Drug Abuse DA033930
6 · The paper itself

Abstract

rationale2-Amino-6-chloro-3,4-dihydroquinazoline (e.g., A6CDQ) represents a novel putative antidepressant originally thought to act through a 5-HT MATERIALS AND

methods5-HT

resultsAlthough A7CDQ binds at 5-HT

conclusionsA simple shift of a substituent in a common quinazoline scaffold from one position to another (i.e., a chloro group from the 6- to the 7-position) resulted in a common action in the TST but via a somewhat different mechanism. A6CDQ and A7CDQ might represent the first members of a new class of potential antidepressants with a unique multi-modal mechanism of action.

Indexed as

AnimalsAntidepressive AgentsDepressionDose-Response Relationship, DrugDrug Therapy, CombinationFemaleHEK293 CellsHindlimb SuspensionHumansLocomotionMaleMiceMice, Inbred ICRQuinazolinesSerotonin AntagonistsXenopus laevisAntidepressive AgentsQuinazolinesSerotonin Antagonists5-HT3 receptorsElectrophysiologyMiceNETOCTSERTTSTUptake-1Uptake-2

Identifiers

PMID30805668
OpenAlexW2917576665

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.